Administration of Paroxetine Attenuates cognitive functon by using fMRI.

Administration of Paroxetine Attenuates cognitive functon by using fMRI. - Administration of Paroxetine Attenuates cognitive functon by using fMRI.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002977

Enrollment

Registered

2010-01-05

Start date

2009-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

1day Paroxetine 20mg 1 time washout duration 2weeks 1day placebo 1 time washout duration 2weeks 1day non drug

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy adult

Exclusion criteria

Exclusion criteria: patients with psychiatric disorder patients with hepatic, kidney, cardiac disorders patients taking other drugs

Design outcomes

Primary

Measure	Time frame
Comparison between placebo, non drug, SSRI conditions.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026